Article
NEJM Evidence  (2023)

Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma

Castillo Gutiérrez, Erika; Janoski De Menezes, Juliana; Shaikh, Anadil; Dolfi, Sonia